Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Medicina Intensiva (English Edition)
OLA strategy for ARDS: Its effect on mortality depends on achieved recruitment (PaO 2 /FiO 2 ) and mechanical power. Systematic review and meta-analysis with meta-regression
V. Modesto i Alapont, A. Medina Villanueva, P. del Villar Guerra, C. Camilo, S. Fernández-Ureña, F. Gordo-Vidal, R. Khemani
10.1016/j.medine.2021.03.001
Med Intensiva. 2021;45:516-31
An ethics crisis within the health crisis due to COVID-19
A. Hernández-Tejedor, M.C. Martín Delgado
10.1016/j.medine.2021.10.005
Med Intensiva. 2021;45:563-5
Intensive Care Medicine: Quiet leadership versus protagonist in times of SARS-CoV-2 pandemic crisis
Á. Estella
10.1016/j.medine.2021.10.006
Med Intensiva. 2021;45:566-7
SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients
J.V. Llau, R. Ferrandis, P. Sierra, F. Hidalgo, C. Cassinello, A. Gómez-Luque, M. Quintana, R. Amezaga, M. Geroi, A. Serrano, P. Marcos
10.1016/j.medine.2021.10.007
Med Intensiva. 2021;45:567-8
Effectiveness of non-invasive ventilation in intensive care unit admitted patients due to SARS-CoV-2 pneumonia
A. Belenguer Muncharaz, H. Hernández-Garcés, C. López-Chicote, S. Ribes-García, J. Ochagavía-Barbarín, R. Zaragoza-Crespo
10.1016/j.medine.2021.10.008
Med Intensiva. 2021;45:e56-8
Interhospital transport of COVID-19 patients on ECMO and comparison with historic controls
P. Blanco-Schweizer, J. Sánchez-Ballesteros, R. Herrán-Monge, A. Prieto-deLamo, J.A. de Ayala-Fernández, M. García-García
10.1016/j.medine.2020.09.007
Med Intensiva. 2021;45:e65-7
Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU
Á. Estella, P. Vidal-Cortés, A. Rodríguez, D. Andaluz Ojeda, I. Martín-Loeches, E. Díaz, B. Suberviola, M.P. Gracia Arnillas, M. Catalán González, F. Álvarez-Lerma, P. Ramírez, X. Nuvials, M. Borges, R. Zaragoza
10.1016/j.medine.2021.08.013
Med Intensiva. 2021;45:485-500
High-flow oxygen therapy in acute hypoxemic respiratory failure secondary to COVID-19 pneumonia
D.A. Godoy, N. Graneros, L. Oyarzabal, F. Murillo-Cabezas
10.1016/j.medine.2021.08.009
Med Intensiva. 2021;45:506-8
The need for rigorous analysis of the effectiveness and efficiency of high flow oxygen therapy during the SARS-CoV-2 pandemic
A. González-Castro, A. Medina, V. Modesto i Alapont, E. Cuenca-Fito, A. Fernandez-Rodríguez, Y. Peñasco
10.1016/j.medine.2021.08.010
Med Intensiva. 2021;45:508-9
Histolo-radiological dissociation in pulmonary fibrosis secondary to SARS-CoV-2 infection
M. Peiro Chamarro, P. Ruiz de Gopegui Miguelena, I. Sampedro Martín, A. Callau Calvo, M.T. Martínez Lamazares, C. Fuertes Schott
10.1016/j.medine.2021.08.006
Med Intensiva. 2021;45:e34-6
Special content about COVID-19
- OLA strategy for ARDS: Its effect on mortality depends on achieved recruitment (PaO 2 /FiO 2 ) and mechanical power. Systematic review and meta-analysis with meta-regression
- An ethics crisis within the health crisis due to COVID-19
- Intensive Care Medicine: Quiet leadership versus protagonist in times of SARS-CoV-2 pandemic crisis
- SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients
Publish in
Medicina Intensiva
Free access articles
Med Intensiva. 2020;44:577-9
Med Intensiva. 2020;44:371-88
Med Intensiva. 2020;44:363-70
